Article

Dr. Claes H. Dohlman, 'founder of modern corneal science,' honored as 2007 Academy Laureate

The highest honor the American Academy of Ophthalmology can bestow was presented to Claes H. Dohlman, MD, PhD, for his distinguished career and contributions to ophthalmology.

The highest honor the American Academy of Ophthalmology can bestow was presented to Claes H. Dohlman, MD, PhD, for his distinguished career and contributions to ophthalmology.

Dr. Dohlman received the award on Nov. 11 at the academy's 2007 annual meeting in New Orleans. In addition, a new Harvard Medical School professorship, named in his honor was announced at a special reception on Nov. 9.

"This honor acknowledges the debt that we all owe to Dr. Dohlman for his contributions to the profession," said C.P. Wilkinson, MD, president of the academy. "In addition to his own remarkable work, his commitment to teaching and education has enabled many of his students to leave their mark on the field of ophthalmology. We are proud to honor his outstanding accomplishments."

Dr. Wilkinson is recognized as the "founder of modern corneal science" and taught young ophthalmologists in the field of cornea for years, making a significant impact on the field of corneal surgery. He has specifically dedicated his time to surgical innovation in keratoplasty and keratoprosthesis. With his clinical and laboratory collaborators Dr. Wilkinson has developed artificial cornea designs, surgical techniques, postoperative treatments, and repair procedures to a degree that has made this procedure considerably more successful.

After receiving his undergraduate and medical degrees from Lund, Sweden, he was invited to Boston to work at the Retina Foundation, the Massachusetts Eye and Ear Infirmary, and Harvard Medical School. Dr. Wilkinson is retired from administrative positions but still works full-time as a professor of ophthalmology.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.